miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway

Chenyang Zhao,Weijia Sun,Pengfei Zhang,Shukuan Ling,Yuheng Li,Dingsheng Zhao,Jiang Peng,Aiyuan Wang,Qi Li,Jinping Song,Cheng Wang,Xiaolong Xu,Zi Xu,Guohui Zhong,Bingxing Han,Yan-Zhong Chang,Yingxian Li
DOI: https://doi.org/10.1080/15476286.2015.1017205
2015-03-04
RNA Biology
Abstract:microRNA is necessary for osteoclast differentiation, function and survival. It has been reported that miR-199/214 cluster plays important roles in vertebrate skeletal development and miR-214 inhibits osteoblast function by targeting ATF4. Here, we show that miR-214 is up-regulated during osteoclastogenesis from bone marrow monocytes (BMMs) with macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL) induction, which indicates that miR-214 plays a critical role in osteoclast differentiation. Overexpression of miR-214 in BMMs promotes osteoclastogenesis, whereas inhibition of miR-214 attenuates it. We further find that miR-214 functions through PI3K/Akt pathway by targeting phosphatase and tensin homolog (Pten). In vivo, osteoclast specific miR-214 transgenic mice (OC-TG214) exhibit down-regulated Pten levels, increased osteoclast activity, and reduced bone mineral density. These results reveal a crucial role of miR-214 in the differentiation of osteoclasts, which will provide a potential therapeutic target for osteoporosis.
biochemistry & molecular biology
What problem does this paper attempt to address?